Sleep Aids Market

Global Market Study on Sleep Aids: Compact Portable CPAP Devices Trending

  • November-2019
  • PMRREP2832
  • 164 Pages
  • Healthcare
  • PPT, PDF, WORD, EXCEL

Rising Sleep Apnea Patient Pool Burgeoning Market Growth

Increasing geriatric population and prevalence of sleep disorders are significantly fuelling sleep aids market growth, with the market anticipated to be valued at US$ 23.5 Bn in 2019. The sleep aids market is expected to exhibit a CAGR of 5% during the forecast period (2019-2029). According to the National Sleep Foundation 2018, more than 18 million individuals in the U.S. experience sleep apnea.

Other factors responsible for the sleep aids market growth includes propelling age, stressful working hours, and increase in consumption of alcohol and tobacco, and changing lifestyles. Delay in the diagnosis can lead to chronic conditions such as risk of heart failure, stroke, high blood pressure, diabetes, and obesity. Growing inclination towards the usage of OTC drugs and devices for monitoring, diagnosing, and treatment of sleep disorders is expected to fuel the demand for sleep aids drugs and devices.

Find Out More about the Report Coverage

Companies

  • ResMed Inc. 
  • Koninklijke Philips N.V.
  • Merck & Co. Inc. 
  • Drive DeVilbiss Healthcare LLC 
  • GlaxoSmithKline Plc. 
  • Fisher & Paykel Healthcare Limited 
  • Sanofi SA 
  • Pfizer Inc

 

Recent Trends Shaping Sleep Aids Market

CPAP (continuous positive aviation route pressure) is a sleep aids therapeutic device used for the treatment therapy of sleep apnea that involves a siphon and mask attached to a tube. Increasing adoption rate of CPAP sleep aids device is mainly attributed to benefits involving improvement in the sleep cycle and relief from snoring.

Organizations such as Philips Respironics, ResMed, Inc. what's more, others are progressively focusing on all sorts of CPAP devices such as in-CPAP humidifiers, which keep air inside the device moist. Portable CPAP sleep aid device is smaller, lighter, and simpler to carry. Individuals are utilizing this compact CPAP sleep aids devices as a locally established unit.

global sleep aids market

Customize this Report

Explore Intelligence Tailored to Your Business Goals.

Increasing Awareness Programs for Management of Sleep Disorders

Healthcare professionals and policy makers are collectively working to increase awareness among general population for the diagnosis and treatment of sleep disorders to reduce burden of chronic sleep loss. There is a rise in sleep apnea cases, which is increasing patient pool seeking medical advice and services for sleep disorders.

To increase awareness for sleep disorders and its consequences, Brazilian Sleep Society promoted “Sleep Week” from March 13, 2017 to March 19, 2017 in Brazil.

Guidance from healthcare professionals and several activities helped in understanding ill effects of sleep disorders. There is a great need for such awareness programs to increase usage of sleep aids devices in regions such as Latin America owing to factors such as lack of skilled healthcare professionals and lack of information for sleep aids devices.

Market Research Methodology - Perfected through Years of Diligence

A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Get actionable insights on Ship Repair And Maintenance Services Market

Regional Analysis – North American Market Preeminent

North America is expected to be the dominant region in the sleep aids market owing to growing incidence of sleep disorders as well as rising geriatric population. For instance, as per the American Sleep Association, 50-70 million US adults have sleeping disorder with 10% of population reported with chronic insomnia, and 30% of population with short-term issues. 25 Million U.S. adults have obstructive sleep apnea out of which, 24-31% of men and 9-21% of women have obstructive sleep apnea.

The Asia Pacific sleep aids market is expected to be a significant revenue generator during the forecast period owing changing lifestyles, increasing consumption of alcohol and tobacco, and stressful working hours.

Awareness campaigns, strategic pricing of products to target price-sensitive consumers and increase in research and development in the region are expected to create lucrative growth opportunities for players in the sleep aids market.

Explore Persistence Market Research’s expertise in promulgation of the business !

Key Market Players Focusing on New Product Launches

The sleep aids market is characterised as a fragmented market. Some of the dominant players include Sanofi SA, GlaxoSmithKline Plc, and Pfizer.Some of the prominent brands offering sleep aids include Ambien CR, QuilliChew ER and Sominex.

New product launches continue to be the preferred developmental strategy of leading companies. In July 2019, Dr. Reddy’s Laboratories launched generic Ramelteon tablets of 8 mg strength for treatment of insomnia in the U.S market.

Analyst’s Viewpoint

Obstructive sleep apnea influences people of all ages, with an increasing predominance in older population more than 60 years. Portal continuous positive airway pressure is the preferred and first line of treatment for sleep apnea in early diagnosed patients for better management of sleep disorders. Manufacturers are working on developing new devices and drugs to combat sleep disorders.

Key Segments of the Sleep Aids Market

PMR’s study on the sleep aids market offers information divided into four important segments-product type, raw material, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Product
  • Drugs
    • Insomnia Treatment Drugs
    • Doxepin Hydrochloride
    • Eszopiclone
    • Ramelteon
    • Triazolam
    • Zaleplon
    • Quazepam
    • Others
    • Narcolepsy Treatment Drugs
    • Modafinil
    • Sodium Oxybate
    • Armodafinil
    • Others
  • Devices
    • CPAP Devices
    • BiPAP Devices
    • APAP Devices
  • Others
    • Mattresses and Pillows
    • Chin Straps
    • Mouth Pieces and Nasal Devices
Indication
  • Insomnia
  • Sleep Deprivation
  • Narcolepsy
  • Sleep Apnea
  • Others
Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • E-Commerce
  • Drug Stores
  • Others
Region
  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East & Africa

Key Questions Answered in PMR’s Sleep Aids Market Report

  • Which regions will continue to remain the most profitable regional markets for sleep aids market players?
  • Which factors will induce a change in the demand for sleep aids during the assessment period?
  • What are the different opportunities available for emerging players in the sleep aids market?
  • How supply-side and demand-side drivers are impacting the sleep aids market?
  • How will changing trends impact the sleep aids market?
  • How can market players capture the low-hanging opportunities in the sleep aids market in developed regions?
  • Which companies are leading the sleep aids market?
  • What are the winning strategies of stakeholders in the sleep aids market to upscale their position in this landscape?

Media Release

Our Clients

Our Clients